Telmijub Beta 40mg/25mg Tablet ER
By Telmijub Beta
Rx
15 Tablet ER in a Strip

Composition
Metoprolol Succinate(25mg) + Telmisartan(40mg)

Manufacturer - Jubilant Life Sciences
1A, Sector 16A, Noida - 201 301, Uttar Pradesh, India

Expires on or after
June, 2026

liver
When using Telmijub Beta 40mg/25mg Tablet ER, it is important to be cautious if you have a liver disease. Patients with liver conditions may require a dose adjustment of Telmijub Beta 40mg/25mg Tablet ER. It is advised to seek guidance from your doctor before using this medication to ensure it is safe and appropriate for you.

kidney
Telmijub Beta 40mg/25mg Tablet ER is safe for patients with kidney disease without the need for dose adjustment.

alcohol
Avoid consuming alcohol while taking Telmijub Beta 40mg/25mg Tablet ER as it is considered unsafe. If pregnant, consult your doctor for guidance.

driving
Telmijub Beta 40mg/25mg Tablet ER can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Telmijub Beta 40mg/25mg Tablet ER is not safe during pregnancy due to potential risk to the developing baby. In life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always seek medical advice.

breastfeeding
Telmijub Beta 40mg/25mg Tablet ER is likely safe to use while breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹185.09
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024